Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-05-08
1998-11-03
Ketter, James
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 241, E07H 2104
Patent
active
058310622
ABSTRACT:
The present invention relates generally to a human interferon consensus gene useful for expression in eucaryotic systems and gene therapy. In particular, the present invention relates to treatment of cancer and cell proliferation disorders through use of viral vectors to deliver and express the human interferon consensus gene in the cells and/or tumors of a patient.
REFERENCES:
Zang, et ala., "Gene Therapy with an Adeno-Associated Virus Carrying an Interferon Gene Results in Tumor Growth Suppression and Regression", Cancer Gene Therapy, vol. 3, No. 1, Jan. 1, 1996-Feb. 1996, pp. 31-38.
Zang, et al., "Treatment of a Human Breast Cancer Xenograft with an Adenovirus Vector Containing an Interferon Gene Results in Rapid Regression Due to Viral Oncolysis and Gene Therapy", Proceedings of the National Academy of Sciences, USA, vol. 93, Apr. 1996, pp. 4513-4518.
Hu, et al., "Loss of Oncogenic Potential of Tumor Cells Following Transduction with the Consensus IFN Gene in an AAV Vector", Journal of Cellular Biochemistry, vol. 0, No. 21A, 1995, p. 422.
Taylor, et al., "Targeting of Human Tumors in Nude Mice with Adenovirus-Associated Vectors Containing the Human Consensus Interferon Gene", 25.sup.th Annual Meeting of the International Society for Experimental Hematology, vol. 23-27, Aug. 1996, New York, New York, USA.
Mackenson et al. Immunostimulatory cytokines in somatic cells and gene therapy of cancer. Cytokine and Growth factor reviews vol. 8(2):119-128,Aug. 11, 1997.
Vieillard et al. Autocrine interferon-beta synthesis for gne therapy of HIV infection: increased resistance to HIV-1 in lymphocytes from healty and HIV-infected individuals. AIDS vol. 9:1221-1228., Nov. 02, 1995.
Glapsy et al. Treatment of hairy cell leukemia with a novel recombinant type-1 interferon, consensus interferon, and granulocyte colony-stimulating factor. J. IFN. Rsch. vol. 12, S1:575, Oct. 07, 1992.
Cao et al. Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon alpha gene therapy in combination with adoptive chemoimmunotherapy. J. Cnacer Res. Clin. Oncol. vol. 121:457-462, Aug. 17, 1995.
Orkin et al. Report and recommendations to the panel to assess teh NIH investments in research on gene therapy., Dec. 07, 1995.
Ferrantini et al. IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. J. Immunol., 153:(10):4604-4615, Nov. 1994.
Blatt Lawrence M.
Taylor Milton W.
Amgen Inc.
Crandell Craig A.
Ketter James
Levy Ron K.
Odre Steven M.
LandOfFree
Use of the human interferon consensus gene for gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of the human interferon consensus gene for gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of the human interferon consensus gene for gene therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-690731